Zanamivir

• CAT Number: A000209
• CAS Number: 139110-80-8
• Molecular Formula: C₁₂H₂₀N₄O₇
• Molecular Weight: 332.31
• Purity: ≥95%
• Synonyms: Relenza; 139110-80-8; Zanamivir hydrate; 4-Guanidino-Neu5Ac2en; GANA
• Target: neuraminidase
• Solubility: >16.6mg/mL in DMSO
• Storage: -20°C
• IUPAC Name: (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
• InChI: InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1
• InChIKey: ARAIBEBZBOPLMB-UFGQHTETSA-N
• SMILES: CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N

Zanamivir（Cat No.:A000209）is an antiviral agent used to treat influenza infections, specifically targeting the neuraminidase enzyme on the surface of the virus. By inhibiting neuraminidase, Zanamivir prevents the release of new viral particles from infected cells, thereby reducing viral spread within the respiratory tract. This compound is effective against both influenza A and B strains. It is commonly administered via inhalation, providing targeted action to the respiratory system. Zanamivir is typically prescribed for individuals with influenza symptoms or those exposed to the virus, offering a tool in managing seasonal flu outbreaks.